ATC/NEMA/AAPM DICOM Demonstration. Walter R. Bosch, D.Sc.

Similar documents
IMRT - the physician s eye-view. Cinzia Iotti Department of Radiation Oncology S.Maria Nuova Hospital Reggio Emilia

RPC Liver Phantom Highly Conformal Stereotactic Body Radiation Therapy

Advanced Technology Consortium (ATC) Credentialing Procedures for 3D Conformal Therapy Protocols 3D CRT Benchmark*

The objective of this lecture is to integrate our knowledge of the differences between 2D and 3D planning and apply the same to various clinical

8/2/2017. Improving Dose Prescriptions for Safety, Reporting, and Clinical Guideline Consistency. Part III

Evaluation of Whole-Field and Split-Field Intensity Modulation Radiation Therapy (IMRT) Techniques in Head and Neck Cancer

Leveraging Innovation to Design Future Clinical Trials. Outline. Multi-Institutional Research 7/15/2015

Dosimetric Comparison of Intensity-Modulated Radiotherapy versus 3D Conformal Radiotherapy in Patients with Head and Neck Cancer

Page 1. Helical (Spiral) Tomotherapy. UW Helical Tomotherapy Unit. Helical (Spiral) Tomotherapy. MVCT of an Anesthetized Dog with a Sinus Tumor

Elekta MOSAIQ and Philips Pinnacle

Treatment Planning & IGRT Credentialing for NRG SBRT Trials

TRANS-TASMAN RADIATION ONCOLOGY GROUP INC. Quality Assurance. Treatment Planning Benchmark

Head and Neck Treatment Planning: A Comparative Review of Static Field IMRT RapidArc TomoTherapy HD. Barbara Agrimson, BS RT(T)(R), CMD

International Multispecialty Journal of Health (IMJH) ISSN: [ ] [Vol-3, Issue-9, September- 2017]

IMRT - Intensity Modulated Radiotherapy

A Comparison of IMRT and VMAT Technique for the Treatment of Rectal Cancer

Helical Tomotherapy Experience. TomoTherapy Whole Brain Head & Neck Prostate Lung Summary. HI-ART TomoTherapy System. HI-ART TomoTherapy System

A Dosimetric Comparison of Whole-Lung Treatment Techniques. in the Pediatric Population

NSABP PROTOCOL B-39B RTOG PROTOCOL 0413

Automated Plan Quality Check with Scripting. Rajesh Gutti, Ph.D. Clinical Medical Physicist

THE TRANSITION FROM 2D TO 3D AND TO IMRT - RATIONALE AND CRITICAL ELEMENTS

ADVANCED TECHNOLOGY CONSORTIUM (ATC) CREDENTIALING PROCEDURES FOR LUNG BRACHYTHERAPY IMPLANT PROTOCOLS

Outline. Contour quality control. Dosimetric impact of contouring errors and variability in Intensity Modulated Radiation Therapy (IMRT)

A guide to using multi-criteria optimization (MCO) for IMRT planning in RayStation

A treatment planning study comparing Elekta VMAT and fixed field IMRT using the varian treatment planning system eclipse

REVISITING ICRU VOLUME DEFINITIONS. Eduardo Rosenblatt Vienna, Austria

Evaluation of Three-dimensional Conformal Radiotherapy and Intensity Modulated Radiotherapy Techniques in High-Grade Gliomas

Intensity modulated radiotherapy (IMRT) for treatment of post-operative high grade glioma in the right parietal region of brain

SBRT fundamentals. Outline 8/2/2012. Stereotactic Body Radiation Therapy Quality Assurance Educational Session

A VMAT PLANNING SOLUTION FOR NECK CANCER PATIENTS USING THE PINNACLE 3 PLANNING SYSTEM *

Protocol of Radiotherapy for Head and Neck Cancer

Defining Target Volumes and Organs at Risk: a common language

PEDIATRIC ORBITAL TUMORS RADIOTHERAPY PLANNING

IGRT Solution for the Living Patient and the Dynamic Treatment Problem

Treatment Planning Evaluation of Volumetric Modulated Arc Therapy (VMAT) for Craniospinal Irradiation (CSI)

New Technologies for the Radiotherapy of Prostate Cancer

Feasibility of the partial-single arc technique in RapidArc planning for prostate cancer treatment

Fiducial-Free Lung Tracking and Treatment with the CyberKnife System: A Non-Invasive Approach

From position verification and correction to adaptive RT Adaptive RT and dose accumulation

A STUDY OF PLANNING DOSE CONSTRAINTS FOR TREATMENT OF NASOPHARYNGEAL CARCINOMA USING A COMMERCIAL INVERSE TREATMENT PLANNING SYSTEM

Independent Dose Verification for IMRT Using Monte Carlo. C-M M Charlie Ma, Ph.D. Department of Radiation Oncology FCCC, Philadelphia, PA 19111, USA

CURRICULUM OUTLINE FOR TRANSITIONING FROM 2-D RT TO 3-D CRT AND IMRT

Chapter 2. Level II lymph nodes and radiation-induced xerostomia

Beam Direction RAO LAO. Pt supine. LL Treatment couch LPO RPO. WHA Consulting. Wilson Apollo

Multi-Case Knowledge-Based IMRT Treatment Planning in Head and Neck Cancer. Shelby Mariah Grzetic. Graduate Program in Medical Physics Duke University

The Physics of Oesophageal Cancer Radiotherapy

Clinical Implementation of SRS/SBRT

Linac Based SBRT for Low-intermediate Risk Prostate Cancer in 5 Fractions: Preliminary Report of a Phase II Study with FFF Delivery

SBRT TREATMENT PLANNING: TIPS + TRICKS. Rachel A. Hackett CMD, RT(T)

Josh Howard CMD Upendra Parvathaneni MBBS, FRANZCR

Treatment Planning for Skull Base Tumors PTCOG 52, June 2013

ICRU Report 91 Was ist neu, was ändert sich?

BREAST CANCER CLINICAL ADVANTAGES

The New ICRU/GEC ESTRO Report in Clinical Practice. Disclosures

Efficient SIB-IMRT planning of head & neck patients with Pinnacle 3 -DMPO

HDR Brachytherapy: Results and Future Studies in Monotherapy

Lung Spine Phantom. Guidelines for Planning and Irradiating the IROC Spine Phantom. MARCH 2014

Evaluation of the Dynamic Arc-Therapy in Comparison to Conformal Radiation Therapy in Radiotherapy Patients

2

IROC Liver Phantom. Guidelines for Planning and Irradiating the IROC Liver Phantom. Revised July 2015

Prostate and Lymph Node VMAT Treatment Planning

Manage TPS in Research and Education

Disclosures. Clinical Implementation of SRS/SBRT. Overview. Anil Sethi, PhD. Speaker: BrainLAB Standard Imaging Research collaboration: RaySearch

MRI Applications in Radiation Oncology:

International RT Clinical Trial Group Membership & Quality Control BY DR YING XIAO

Dosimetric Analysis of 3DCRT or IMRT with Vaginal-cuff Brachytherapy (VCB) for Gynaecological Cancer

AllinaHealthSystems 1

Assessing Heterogeneity Correction Algorithms Using the Radiological Physics Center Anthropomorphic Thorax Phantom

Potential benefits of intensity-modulated proton therapy in head and neck cancer van de Water, Tara Arpana

IROC Lung Phantom 3D CRT / IMRT. Guidelines for Planning and Irradiating the IROC Lung Phantom. Revised Dec 2015

Dosimetric Effects of Using Generalized Equivalent Uniform Dose (geud) in Plan Optimization

RTOG DOSIMETRY DATA SUBMISSION

It s All About Margins. Maaike Milder, Ph.D. Accuray Symposium April 21 st 2018

Hybrid VMAT/IMRT Approach to Traditional Cranio-Spinal Irradiation (CSI): A Case Study on Planning Techniques and Delivery

Credentialing for the Use of IGRT in Clinical Trials

Three-Dimensional Conformal Radiotherapy (3DCRT) Treatment planning for external photon beam

Monte Carlo Dose Calculation for Radiotherapy Treatment Planning

IMRT IN HEAD NECK CANCER

New research in prostate brachytherapy

Radiation Damage Comparison between Intensity Modulated Radiotherapy (IMRT) and Field-in-field (FIF) Technique In Breast Cancer Treatments

Transperineal Interstitial Permanent Prostate Brachytherapy (TIPPB) Quality Assurance Guidelines

Anatomy. Contents Brain (Questions)

Fast cine-magnetic resonance imaging point tracking for prostate cancer radiation therapy planning

Report of ICRU Committee on Volume and Dose Specification for Prescribing, Reporting and Recording in Conformal and IMRT A Progress Report

Vaginal Sparing with Volumetric Modulated Arc Therapy (VMAT) for Rectal Cancer. Scott Boulet BSc, RT(T)

Ashley Pyfferoen, MS, CMD. Gundersen Health Systems La Crosse, WI

PROSTATE CANCER BRACHYTHERAPY. Kazi S. Manir MD,DNB,PDCR RMO cum Clinical Tutor Department of Radiotherapy R. G. Kar Medical College

Trina Lynd, M.S. Medical Physicist Lifefirst Imaging & Oncology Cullman, AL Tri-State Alabama, Louisiana and Mississippi Spring 2016 Meeting April

The Evolution of RT Techniques for Gynaecological Cancers in a developing country context

Specification of Tumor Dose. Prescription dose. Purpose

IMPT with Carbon Ions

Department of Radiotherapy & Nuclear Medicine, National Cancer Institute, Cairo University, Cairo, Egypt.

Radiotherapy Planning (Contouring Lung Cancer for Radiotherapy dose prescription) Dr Raj K Shrimali

Clinical Report for Wanjie Proton Therapy Center. Li Jiamin, MD Wanjie Proton Therapy Center

Intensity-modulated radiation therapy for nasopharyngeal carcinoma: a review

Evaluation of Monaco treatment planning system for hypofractionated stereotactic volumetric arc radiotherapy of multiple brain metastases

Knowledge-Based IMRT Treatment Planning for Prostate Cancer: Experience with 101. Cases from Duke Clinic. Deon Martina Dick

IMRT for Prostate Cancer

IMAT: intensity-modulated arc therapy

IGRT Protocol Design and Informed Margins. Conflict of Interest. Outline 7/7/2017. DJ Vile, PhD. I have no conflict of interest to disclose

Transcription:

ATC/NEMA/AAPM DICOM Demonstration Walter R. Bosch, D.Sc.

Two-Phase Strategy for DICOM Demonstration 1. Demonstrate export of ATC-Compliant DICOM RT objects (or as large a subset as possible) 2. Demonstrate import of RT objects exported in Phase 1. Bosch Mar. 2004 2

DICOM Demonstration Strategy Step 1: DICOM Export 1. Distribute a modest test suite as a starting point for manufacturers: a. CT Image Series (DICOM) b. RT Structure Set (DICOM) c. Instructions for creating treatment plans 2. Manufacturers a. Import images, structures b. Create plans c. Export CT images, RT Structure Set; RT Plan, RT Dose, RT Image 3. Display and compare data submitted by manufacturers ATC web-based review tools (RRT, NetSys) Computation Environment for Radiotherapy Research (CERR) Bosch Mar. 2004 3

DICOM Demonstration Strategy Step 2: DICOM Import 1. Provide a library of manufacturers DICOM objects for off-line testing: a. Includes as much as possible, CT Images, RT Structure Set, RT Plan, RT Dose, RT Image from Step 1. b. ATC web-based review tools provide displays of what data should look like. 2. Demonstrate exchange using a. Manufacturer-to-manufacturer network exchange b. Central Test Node (ATC, AAPM, Merge,???) c. Media exchange Bosch Mar. 2004 4

DICOM Test Data Starting point for treatment planning De-identified Remove hidden identifiers New instance UIDs Minimize obstacles for importing into treatment planning systems Remove private tags Structure Sets contour Z positions coincide with those of CT slices Available both as LittleEndian/ImplicitVR Datasets, and as Part-10 Filesets Bosch Mar. 2004 5

DICOM Pushset Script.\pushset.bat <DCMDIR> <APP_TITLE> <HOST> <PORT_#> Where: DCMDIR is the DICOM file directory one level below this scripts directory on the CD APP_TITLE is the AE_TITLE of the DICOM receiver host HOST is the host name (or IP address of the DICOM receiver) PORT_# is the port number (usually 104) of the DICOM receiver Example:.\pushset.bat ATC04PR02 STORESCP rtp1.mydomain 104 Bosch Mar. 2004 6

DICOM Test Data Sets 1. ATC04PR02 3D-Conformal Prostate Conforms to RTOG protocol 0126 2. ATC04HN02 IMRT Head/Neck Conforms to RTOG protocol 0225 Bosch Mar. 2004 7

Case 1 (ATC04PR02) Data 97 CT slices 10 Structures: PTV2 (high-dose) PTV1 (low-dose) Prostate/SV [CTV1] CTV2 Bladder Rcctum RT Femur Lt Femur Penile bulb Skin Bosch Mar. 2004 8

Case 1 (ATC04PR02) Plan Specifications 2 fraction groups (sub-plans) with 6 beams each Gantry ICRU Ref Point Dose (cgy) Initial Boost RPO 315 837 351 RLat 270 1224 514 RAO 225 837 351 LAO 135 837 351 Llat 90 1224 514 LPO 45 837 351 Total 5796 2432 Bosch Mar. 2004 9

Case 1 (ATC04PR02) Target Volume Prescription Prescription (ICRU Ref Dose) PTV1: 57.97 Gy PTV2: 82.28 Gy (44 fractions) Minimum dose PTV1: 95% RxD = 55 Gy PTV2: 95% RxD = 78 Gy Coverage score (minimum dose) 100% = no variation 95% = minor variation < 95% = major variation Maximum dose to PTV2 107% RxD = no variation 110% RxD = minor variation > 110% RxD = major variation Bosch Mar. 2004 10

Case 1 (ATC04PR02) Normal Tissue Guidelines Maximum Dose to Percent of Volume 15% 25% 35% 50% Bladder 80 Gy 75 Gy 70 Gy 65 Gy Rectum 75 Gy 70 Gy 65 Gy 60 Gy Bosch Mar. 2004 11

Case 2 (ATC04HN02) Data 107 CT slices 28 structures Bosch Mar. 2004 12

Case 2 (ATC04HN02) Target Volumes Target volumes CTV70 = GTV + microscopic extensions PTV70 = CTV70 + 0.5 cm CTV59.4 = cervical lymph nodes at high risk PTV59.4 = CTV59.4 + 0.5 cm Bosch Mar. 2004 13

Case 2 (ATC04HN02) Prescription 33 Fractions, 5 fractions per week, all fields treated once daily Rx Dose: 70Gy (PTV70), 59.4Gy (PTV59.4) No variation: 95% of PTV at or above RxD or 99% of PTV at or above 93% of RxD Minor variation: 95% of PTV at or above 93% of RxD Major variation: < 95 % of PTV at or above 93% of RxD Dose heterogeneity No variation: no more than 20% of either PTV is at or above 77Gy Minor variation: nor more than 5% of either PTV is at or above 80.5 Gy Bosch Mar. 2004 14

Case 2 (ATC04HN02) Normal Tissue Constraints Organ at Risk Temporal lobes Dose Limit and Criteria 60 Gy or 1% of Vol. > 65 Gy Brainstem, optic nerves, chiasm Spinal cord 54 Gy or 1% of Vol. > 60 Gy 45 Gy or 1 cc > 50 Gy Mandible, TMJ 70 Gy or 1cc > 75 Gy Parotid glands Mean dose to either gland < 26 Gy, or 50% of either gland receives < 30 Gy, or 20cc of combined glands receives < 20 Gy Minor variation: 40% of either gland receives < 30 Gy Bosch Mar. 2004 15

DICOM Objects to Be Submitted to ATC CT Image RT Structure Set RT Dose (3D dose distribution) for each fraction group RT Plan RT Dose (DVH) for total dose plan RT Image (DRRs) Bosch Mar. 2004 16

Review Tools for Display of Data ITC Remote Review Tool RCET NetSys Client CERR Bosch Mar. 2004 17

Remote Review Tool CT Images (zoom, window/level) Structure contours (review, editing) Iso-dose contours Interactive DVH Point-dose display Bosch Mar. 2004 18

Computational Environment for Radiotherapy Research (CERR) J. Deasy, Washington Univ. Bosch Mar. 2004 19

Submission Timeline Vendors submit DICOM data to ITC until June 25, 2004 FTP to castor.wustl.edu CD-R WebSys (contact Walter Bosch, itc@castor.wustl.edu for account) AAPM 46th meeting July 25-29, 2004 Network CD-R USB drive Bosch Mar. 2004 20

Email from Dwight Simon 2/14/04 Walter/et al, I've tried to keep track of all the things that go on in WG7 over the years, but I certainly haven't done an adequate job. However, I am aware of the great amount of energy and effort that has been put into developing the RT portion of DICOM over the years and I would like to applaud your diligence and accomplishments. I believe, that you have the most complex set of DICOM objects in the standard and, this is where the difficulty has come in for getting it all to work in a fully interoperable environment. I wish you the best of luck in this latest demonstration endeavor and would like to encourage everyone to participate to there fullest extent. I think you are on the verge of really making it happen - if you get full and in depth participation. Best Regards, Dwight Bosch Mar. 2004 21